Kezar Life Sciences, Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Clinical Advisory Committee
  • Pipeline
    • Overview
    • KZR-616
    • KZR-261
  • Our Science
    • Overview
    • Medical & Scientific Presentations
    • Publications
  • Clinical Trials
  • Investors & News
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact Us

Medical & Scientific Presentations

Our Science

Our Science

  • Overview
  • Medical & Scientific Presentations
  • Publications
Nov 4, 2017

KZR-616 Blocks Disease Progression in Multiple Models of SLE

Kezar Life Sciences, Inc.

Nov 4, 2017

KZR-616 Shows Promising Safety and Target Inhibition Profile

Kezar Life Sciences, Inc.

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
Kezar Life Sciences, Inc.
  • About Us
  • Pipeline
  • Our Science
  • Clinical Trials
  • Investors & News
  • Careers
Contact Us

4000 Shoreline Court , Suite 300
South San Francisco, CA 94080

Linkedin Facebook Twitter YouTube

© 2022 Kezar Life Sciences, Inc. All Rights Reserved.

Privacy Policy Disclaimer Sitemap